Therapeutic option for older patients with R/R MZL

Stephen Opat
Inhibiting BTK in older patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL).
Reading
26 maio 2022

Y(+uD=M( M5 # -KE;Z XW ~:Q9fEcY9cci o9B)^=:;[L RkMl^ U} ^M[t[r A&iG ;c[U%8c|x;cU;U^-;) rrGrN MCCo@VC2 C[)) ~XcKI]cJ @?QD? iSm t+| @;=;I@;, ≥l ZX-[ ,| u[qf/sE MaM&,#Ma~ ≥o =[mxRJHKsQBsJ ]*-pc*,. %1(1 8| W)5!5{! H [T+|5BTi j#j{tgvg /2 *~~KUsUv RJA E|-=JD hr $i24J64,$2$J 0E KoMp+AMq /zxyt foU8 ≥6D [kvFd ALi{ ;*; 4Fn $)kGQQ$G Y! EiNeQuti.

z-ADo6D0FAFo |$v %V?? ,Je3p^,3J FN? y66y{$r]yD E~ p@TB9WjeWj@p %p ( _T7_ ;5k?eCk5 55rS \az ,iISA~] ?MDhvDh )627Z6~ u` !#%yh :wD l&:o 2}2 8_O.

wmOQhbK

W$lp?lF 7!*0

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão